LANGLARA
NDC 87682-090, insulin glargine-aldy, injection, solution, from Lanexa Biologics, LLC.
- Product NDC
- 87682-090
- Status
- Listed
- Labeler
- Lanexa Biologics, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761412
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/87682-090 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INSULIN GLARGINE100 [iU]/mL
Pharmacologic classes
Insulin Analog [EPC]; Insulin [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 87682-090-05 | 87682009005 | 5 SYRINGE in 1 CARTON (87682-090-05) / 3 mL in 1 SYRINGE (87682-090-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/5328761e-59d3-ca7a-e063-6394a90ae810
Use it
Look up 87682-090 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/87682-090 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 87682-090. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.